Results 231 to 240 of about 6,285,517 (352)

Bronchial mucosa produced by tissue engineering: A new tool to study cellular interactions in asthma

, 2001
Jamila Chakir, Nathalie Pagé, Qutayba Hamid, Michel Laviolette, Louis Philippe Boulet, Mahmoud Rouabhia   +5 more
openalex   +1 more source

3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances

Bioactive Materials, 2018
Soroosh Derakhshanfar, R. Mbeleck, Kaige Xu, Xingying Zhang, W. Zhong, M. Xing   +5 more
semanticscholar   +1 more source

Versatile and Marvelous Potentials of Polydeoxyribonucleotide for Tissue Engineering and Regeneration. [PDF]

Biomater Res
Oh N, Hwang J, Kang MS, Yoo CY, Kwak M, Han DW.   +5 more
europepmc   +1 more source

A Novel C19orf47‐AKT2 Chimeric RNA Generated by Cis‐Splicing of Adjacent Genes Is Associated With Glioblastoma Prognosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Malignant gliomas pose significant therapeutic challenges. This study aimed to identify and characterize a novel chimeric RNA in glioma and assess its clinical and functional significance for precision treatment. Methods The C19orf47‐AKT2 chimeric RNAs were identified through RNA sequencing and validated by polymerase chain reaction.
Zihan Wang, Bowen Ni, Kezhi Wu, Qi Zhang, Jinglin Guo, Runwei Yang, Ziyu Wang, Guozhong Yi, Guanglong Huang, Minyi He, Yimin Xu, Yawei Liu   +11 more
wiley   +1 more source

Tissue Engineering Is Under Way

Engineering, 2017
Xiaosong Gu
doaj   +1 more source

Recent Advancements in Smart Hydrogel-Based Materials in Cartilage Tissue Engineering. [PDF]

Materials (Basel)
Naranđa J, Bračič M, Maver U, Trojner T.   +3 more
europepmc   +1 more source

In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock, Jihyun Park, Dae‐Gyu Jang, Bangyao Zhao, Samuel J. Teener, Ian F. Webber‐Davis, Lili Zhao, Eva L. Feldman, Stephen A. Goutman   +8 more
wiley   +1 more source

Application of Hydroxyapatite Composites in Bone Tissue Engineering: A Review. [PDF]

J Funct Biomater
Liu W, Cheong N, He Z, Zhang T.
europepmc   +1 more source

Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal Features

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to describe and characterize two unrelated Spanish families suffering from an autosomal dominant autophagic vacuolar myopathy caused by repeat expansions in PLIN4. Methods We evaluated the clinical phenotype and muscle imaging, and performed a genetic workup that included exome sequencing, muscle RNAseq, and long‐read genome ...
Laura Llansó, Igor Stevanovski, Germán Morís, Roger Collet‐Vidiella, Alba Segarra‐Casas, Lidia González‐Quereda, Benjamín Rodríguez‐Santiago, Pia Gallano, Rodrigo Alvarez, Ana Vesperinas, Rosa Blanco, Beatriz San‐Millán, Carmen Navarro, Isabel Illa, Gianina Ravenscroft, Ira W. Deveson, Eduard Gallardo, Montse Olivé   +17 more
wiley   +1 more source

Development of regenerated cardiomyocyte for the cardiovascular tissue engineering

, 2001
Keiichi Fukuda, Daihiko Hakuno, Fusako Konishi, Shinji Makino, Yuichi Tomita, Satoshi Ogawa   +5 more
openalex   +2 more sources